Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cardiac myocardial cell membrane, commonly referred to as the sarcolemma, is the specialized plasma membrane surrounding cardiac muscle cells (cardiomyocytes) [1, 4]. It serves as a critical interface for excitation-contraction coupling, housing a complex network of ion channels, transporters, and receptors that regulate the electrical activity and contractile force of the heart [1, 3]. Key components embedded within this lipid bilayer include voltage-gated sodium and calcium channels, various potassium channels, and the sodium-potassium pump (Na+/K+-ATPase), which together maintain the resting membrane potential and generate action potentials [3, 4]. In pathological states such as myocardial infarction or heart failure, the structural integrity of the sarcolemma is often compromised, leading to the leakage of intracellular proteins like troponins into the systemic circulation, which serve as gold-standard clinical biomarkers for cardiac injury [2]. While the sarcolemma itself is a multi-component cellular structure rather than a single molecular therapeutic target, it is the primary site of action for a wide range of cardiovascular drugs, including beta-blockers, calcium channel blockers, and antiarrhythmic agents [3]. Understanding the sarcolemma's composition and its remodeling during disease is essential for developing therapies that stabilize cardiac rhythm and improve myocardial function [1, 3]. Sources: [1] StatPearls, "Physiology, Cardiac Muscle" (https://www.ncbi.nlm.nih.gov/books/NBK537113/) [2] NIH, "Cardiac Biomarkers" (https://www.ncbi.nlm.nih.gov/books/NBK545211/) [3] PubMed, "Ion channels of the sarcolemma" (https://pubmed.ncbi.nlm.nih.gov/11566057/) [4] Wikipedia, "Sarcolemma" (https://en.wikipedia.org/wiki/Sarcolemma)
Modulation of membrane-bound ion channels (sodium, potassium, calcium), transporters (Na+/K+-ATPase), and G protein-coupled receptors to regulate cardiac rhythm, excitability, and contractility.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac myocardial cell membrane.